ARCHIVED


Medical Policy                            

Policy Num:      02.007.008
Policy Name:    Electroencephalograms (EEG)
Policy ID:          [02.007.008]  [Ar / B / M+ /P+]  [2.01.14]


Last Review:      July 11, 2023
Next Review:      Policy Archived
 

ARCHIVED

Related Policies: None

Electroencephalograms (EEG)

Population Reference No.

Populations

Interventions

Comparators

Outcomes

1

Individuals

  • With altered consciousness, atypical seizure variants, head injury, differentiation of complicated migraine with epilepsy-like symptoms when closest medical facilities are in remote areas which lack trained EEG interpreters
  •  during provocation testing which can be safely undertaken only in the immediate proximity of emergency medical personnel and technology
  • localize the seizure focus prior to surgery when ambulation is desirable        

Interventions of interest are:

  • Ambulatory EEG by telephone, radio, or cable

Comparators of interest are:

  • Management without ambulatory EEG

Relevant outcomes are:

  • Net health outcome      

2

Individuals:

  • With seizures suspected of cardiogenic origin or connected to sleep disturbances, quantification of absence seizures and with environmental triggers       

Interventions of interest are:

  • Ambulatory twenty-four-hour EEG with cassette-recording

   

Comparators of interest are:

  • Management without 24 hr ambulatory cassette recorded EEG 

Relevant outcomes are:

  • Net health outcome       

3

Individuals:

  • Where a diagnosis could not be made based on a neurological examination, routine EEG reporting, and ambulatory cassette EEG monitoring.

Interventions of interest are:

  • Ambulatory twenty-four-hour EEG with Video Monitoring

 

Comparators of interest are:

  • Management without 24 hr ambulatory EEG with video recording

Relevant outcomes are:

  • Net health outcome  

Summary

An electroencephalogram (EEG) is a recording of electrical current potentials spontaneously from nerve cells in the brain onto the skull. Variations in wave characteristics correlate with neurological conditions and are used to diagnose conditions.

 

EEGs can be transmitted by telephone in which electrical brain activity is recorded and transmitted to an off-site center for interpretation and report or by radio or cable in the diagnosis of complex seizure variants which require inpatient monitoring, but do not require the patient to be in bed.

 

EEGs can be recorded by 24-hour ambulatory cassette. Twenty-four-hour ambulatory cassette-recorded EEGs offer the ability to record the EEG on a long-term, outpatient basis. Electrodes for at least 4 recording channels are secured on the patient. The cassette recorder is attached to the patient’s waist or on a shoulder harness. Recorded electrical activity is analyzed by playback through an audio amplifier system and video monitor.

 

Electroencephalographic video monitoring is the simultaneous recording of the EEG and video monitoring of patient behavior. This allows for the correlation of ictal and interictal electrical events with demonstrated or recorded seizure symptomology. This type of monitoring allows the patient’s face or entire body to be displayed on a video screen.

Objective

The objective of this review is to determine whether the use of EEG can improve the net health outcome of patients in a variety of neurological conditions and settings.

Policy Statements

Transmission of the EEG by telephone, radio, or cable is considered medically necessary when the closest medical facilities are located in remote areas with untrained EEG interpreters for patients with the following indications:

· Altered consciousness, such as stuporous, semi-comatose, or comatose states;

· Atypical seizure variants in patients experiencing bizarre, distressing symptoms as seen with “spike and wave stupor” or other forms of seizure disorders;

· Head injury, where a subdural hematoma may be identified; or

· Differentiation of complicated migraine with epilepsy-like symptoms (e.g., auras, alterations in level of consciousness) from true seizure disorders.

 

Radio and cable telemetry of the EEG is considered medically necessary with prior approval for:

· EEG recording during provocation testing (e.g., withdrawal of anticonvulsant medications), which can be safely undertaken only in the immediate proximity of emergency medical personnel and technology; and

· EEG recording attempting to localize the seizure focus prior to surgery when ambulation is desirable (e.g., when seizures are triggered by specific environmental stimuli or daily events).

 

Telephone transmission of the EEG to determine electrocerebral silence, i.e., brain death, is considered investigational.

 

Twenty-four-hour ambulatory cassette-recorded EEGs are medically necessary with prior approval in the following circumstances:

· When used in conjunction with ambulatory electrocardiogram (ECG) recordings for seizures suspected to be of cardiogenic origin;

· When used in conjunction with electrooculogram (EOG) and electromyogram (EMG) recordings for suspected seizures of sleep disturbances;

· When used for quantification of seizures in patients who experience frequent absence seizures; and

· When used in documenting seizures that are precipitated by naturally occurring cyclic events or environmental stimuli that are not reproducible in the hospital or clinical setting.

 

Twenty-four-hour ambulatory cassette-recorded EEGs are considered investigational in the following circumstances:

· For the study of neonates or unattended, noncooperative patients;

· In localization of seizure focus/foci when the seizure symptoms and/or other EEG recordings indicate the presence of bilateral foci or rapid generalization; and

· For final evaluation of patients who are being considered as candidates for resective surgery.

Video/EEG monitoring is considered medically necessary with prior approval when used to confirm the diagnosis of cases of complex seizures where treatment is defined by the seizure type. EEG video monitoring is useful for patients where a diagnosis could not be made on the basis of a neurological examination, routine EEG reporting, and ambulatory cassette EEG monitoring.

Policy Guidelines

 See policy.

Benefit Application

BlueCard/National Account Issues

State or federal mandates (eg, Federal Employee Program) may dictate that certain U.S. Food and Drug Administration-approved devices, drugs, or biologics may not be considered investigational, and thus these devices may be assessed only by their medical necessity.

 

Benefits are determined by the group contract, member benefit booklet, and/or individual subscriber certificate in effect at the time services were rendered.  Benefit products or negotiated coverages may have all or some of the services discussed in this medical policy excluded from their coverage.

Background

A seizure is a transient episode of symptoms and/or signs due to abnormal excessive or synchronous neuronal activity in the brain. A seizure does not necessarily mean that a person has epilepsy unless criteria for a diagnosis of epilepsy are met. There are numerous conditions that can be associated with convulsive events that can resemble seizures/epilepsy, these should be carefully excluded (Epilepsy Foundation, 2018). Epilepsy is diagnosed when: at least two unprovoked (or reflex) seizures occur more than 24 hours apart, or one unprovoked (or reflex) seizure with a probability of further seizures occurring over the next ten years or a diagnosis of an epilepsy syndrome (Schachter, 2018).

Epilepsy is a disorder caused by the excessive and intense activity of certain neurons in the brain. The seizures caused by this activity can last for several minutes and, depending on the region of the brain affected, they can bring about fainting, involuntary and violent shaking, or brief episodes of unconsciousness. Epilepsy can have a genetic origin or result from brain damage, and for some individuals, its underlying cause may not be determined. The seizures that result from this abnormal neuron activity in the brain may be caused by neurological imbalances, or medical conditions (i.e., drug or alcohol withdrawal). Therefore, seizure type and precipitating causes should be identified to determine the best course of treatment.

The diagnosis of epilepsy can be complicated, and it is not unusual to have a misdiagnosis. Diagnosing epileptic seizures is made by analyzing the patient’s clinical history, laboratory results, and an electroencephalogram (EEG). An EEG is an important diagnostic test in assessing a patient with potential epilepsy. It can support the diagnosis of epilepsy and also assist in classifying the underlying epileptic syndrome. An EEG measures the electrical activity of the brain (i.e., brainwaves) using recording equipment attached to the scalp by electrodes. The EEG is used in the evaluation of brain disorders, and most commonly used to show the type and location of the activity in the brain during a seizure. It may also be used to evaluate problems associated with brain function such as confusion and long-term difficulties with thinking or memory.

An EEG is obtained to document the presence and frequency of abnormal neuron activity. In most cases, a routine EEG can identify brain activity specific to seizures. The EEG can provide support for the diagnosis of epilepsy and also assists in classifying the underlying epileptic syndrome. However, there are several reasons why in some cases a routine EEG alone cannot be used to make or refute a specific diagnosis of epilepsy (Moeller, et al., 2018):

• Most EEG patterns can be caused by a wide variety of different neurologic diseases.

• Many diseases can cause more than one type of EEG pattern.

• Intermittent EEG changes, including interictal epileptiform discharges, can be infrequent and may not appear during the relatively brief period of routine EEG recording.

• The EEG can be abnormal in some persons with no other evidence of disease.

• Not all cases of brain disease are associated with an EEG abnormality, particularly if the pathology is small, chronic, or located deep in the brain.

For some individuals diagnosed with epilepsy, the EEG may remain normal. Spike discharges may not be captured on an EEG because their occurrence is rare or their site of origin is very small or within an occult area of the cortex. Spike activity can also be affected by antiepileptic medication (Blume, 2005; Aminoff, 2003). A normal patient may also show unusual brain activity on an EEG and be incorrectly diagnosed. When a definitive diagnosis cannot be made from a clinical examination and a resting EEG, additional testing may be necessary (e.g., ambulatory EEG, video EEG). A prolonged 24-hour ambulatory EEG in the outpatient/home setting may be used to differentiate between the presence of epileptic, non-epileptic or psychogenic seizure disorders. The focus of this Coverage Policy is ambulatory EEG.

Ambulatory Electroencephalography (EEG)

Ambulatory or 24-hour EEG monitoring is performed by a recorder that continuously records brain wave patterns during a patient's routine daily activities and sleep up to 72 hours. An ambulatory EEG can be done with or without video recording. The monitoring equipment includes an electrode set, preamplifiers, and a recorder. The electrodes attach to the scalp, and the leads are connected to a recorder, usually worn on a belt. Ambulatory EEG allows patients to be evaluated in their natural environments, with exposure to potential stressors and other seizure triggers.

Prolonged continuous ambulatory EEG recording throughout one or more complete natural sleep/wake cycles increases the likelihood of documenting an ictal episode. The most helpful finding on EEG is interictal epileptiform discharges (IEDs). Identification of interictal epileptiform discharges, which are EEG patterns believed to be associated with a relatively high risk for having seizures, have been reported as occurring in 95% of epilepsy patients within 48 hours of monitoring (Tatum, et al., 2018; Seneviratne, et al., 2013; Faulkner, et al., 2012). Routine EEG has low sensitivity in epilepsy ranging from 25%–56%, with a specificity of 78%–98% (Smith, 2005). Serial routine EEGs, studies performed a short time after an epileptic seizure as well as sleepdeprived EEG studies increase the overall diagnostic yield. However, those methods are usually considered inferior to long-term EEG monitoring, where the duration of recording is measured in hours or days (Keezer, et al., 2016).

Ambulatory EEG recordings can be utilized in the evaluation and differential diagnosis of non-epileptic seizures if these episodes are unable to be diagnosed by conventional studies. There are two categories of non-epileptic seizures: pathophysiological events and non-epileptic psychopathological/psychiatric events. Pathophysiological events include: autonomic disorders, cardiac arrhythmias, drug toxicity, metabolic disorders, migraines, orthostatic hypotension, sleep disorders, valvular heart disease, vasovagal syncope and vestibular disorders. Non-epileptic psychopathological/psychiatric events include: anxiety, depression, panic attacks, psychogenic seizures and psychosis (Mesraoua, 2012).

Syncope, for example, shares some clinical characteristics with seizures which may lead to diagnostic confusion. Seizures and syncope may also coexist in a given individual. In general, a syncopal episode or temporary loss of consciousness may be considered unrelated to epilepsy if any of the following features are present:

• prodromal symptoms that on other occasions have been abolished by sitting or lying down

• sweating before the episode

• prolonged standing that appeared to precipitate the temporary loss of consciousness

• pallor during the episode

Sleep and sleep stage have a significant impact on the incidence and frequency of both seizures and epileptiform discharges that occur in between seizures. Generally, non-rapid eye movement (NREM) sleep facilitates interictal epileptiform discharges (IED) and seizures, while rapid eye movement (REM) sleep tends to inhibit seizures. Prolonged outpatient ambulatory, inpatient video-EEG recordings, or overnight video-EEG polysomnography, are of higher yield in detecting IEDs and capturing seizures in the sleep-related focal epilepsies (St Louis et al., 2018).

Literature Review: The diagnostic accuracy of ambulatory EEG has not been well studied. Authors have reported through several retrospective studies with patient populations ranging from 46–344, the value of adding ambulatory EEG to standard EEG recording data in confirming the presence or absence of epileptic conditions. In a prospective study (n=72) by Keezer et al. (2016), the sensitivity of ambulatory EEG was reported to be 2.23 times greater than that of routine EEG (p<0.0001). Ambulatory EEG results have been reported to change clinical management in up to 51% of patients. The median duration of recording was 1.4 days (Faulkner, et al., 2012). Prolonged ambulatory EEG has been found to have a higher probability of recording an epileptic event relative to sleep-deprived EEG (15.2% versus 0%, respectively; p=0.01) (Liporace, et al., 1998).The published peer-reviewed medical literature contains some evidence primarily in the form of case series to support the use of ambulatory EEG. While the supporting evidence is not robust, the use of ambulatory EEG monitoring has become a standard of care within the armamentarium of diagnostic evaluations of epilepsy versus a nonepileptic syndrome for a subset of individuals.

Regulatory Status

N/A

Rationale

Evidence reviews assess whether a medical test is clinically useful. A useful test provides information to make a clinical management decision that improves the net health outcome. That is, the balance of benefits and harms is better when the test is used to manage the condition than when another test or no test is used to manage the condition.

The first step in assessing a medical test is to formulate the clinical context and purpose of the test. The test must be technically reliable, clinically valid, and clinically useful for that purpose. Evidence reviews assess the evidence on whether a test is clinically valid and clinically useful. Technical reliability is outside the scope of these reviews, and credible information on technical reliability is available from other sources.

A search of literature was completed through the MEDLINE database for the period of January 1990 through October 1995. The search strategy focused on references containing the following Medical Subject Headings: 

-Cassette

- Electroencephalography

- Radio or Cable

- Telephone

- Video Research was limited to English-language journals on humans.

 See also:

TEC Evaluation and Coverage 1988: p. 212

Population Reference No. 1 

Transmission of the EEG by telephone, radio, or cable is considered medically necessary when the closest medical facilities are located in remote areas with untrained EEG interpreters for patients with the following indications:

· Altered consciousness, such as stuporous, semicomatose, or comatose states;

· Atypical seizure variants in patients experiencing bizarre, distressing symptoms as seen with “spike and wave stupor” or other forms of seizure disorders;

· Head injury, where a subdural hematoma may be identified; or

· Differentiation of complicated migraine with epilepsy-like symptoms (e.g., auras, alterations in level of consciousness) from true seizure disorders.

· EEG recording during provocation testing (e.g., withdrawal of anticonvulsant medications), which can be safely undertaken only in the immediate proximity of emergency medical personnel and technology; and

· EEG recording attempting to localize the seizure focus prior to surgery when ambulation is desirable (e.g., when seizures are triggered by specific environmental stimuli or daily events).

Population Reference No. 1

Policy Statement

[X] Medically Necessary [ ] Investigational

Population Reference No. 2 

Ambulatory or 24-hour electroencephalographic (EEG) monitoring is accomplished by a cassette recorder that continuously records brain wave patterns during sleep and 24 hours of a patient's routine daily activities. The monitoring equipment consists of preamplifiers, an electrode set, and a cassette recorder. The electrodes attach to the scalp, and their leads are connected to a recorder.

Ambulatory EEG monitoring is a diagnostic procedure for patients in whom a seizure diathesis is suspected but not defined by history, physical or resting EEG.Ambulatory EEG should always be preceded by a resting EEG. 

Twenty-four hour ambulatory cassette-recorded EEGs are medically necessary with prior approval in the following circumstances: 

· When used in conjunction with ambulatory electrocardiogram (ECG) recordings for seizures suspected to be of cardiogenic origin;

· When used in conjunction with electrooculogram (EOG) and electromyogram (EMG) recordings for suspected seizures of sleep disturbances;

· When used for quantification of seizures in patients who experience frequent absence seizures; and

· When used in documenting seizures that are precipitated by naturally occurring cyclic events or environmental stimuli that are not reproducible in the hospital or clinic setting.

Twenty-four hour ambulatory cassette-recorded EEGs are considered investigational in the following circumstances: 

· For the study of neonates or unattended, noncooperative patients;

· In localization of seizure focus/foci when the seizure symptoms and/or other EEG recordings indicate the presence of bilateral foci or rapid generalization; and

· For final evaluation of patients who are being considered as candidates for resective surgery.

 

Population Reference No. 2

Policy Statement

[X] Medically Necessary [ ] Investigational

Population Reference No. 3 

Video/EEG monitoring is considered medically necessary with prior approval when used to confirm the diagnosis of cases of complex seizures where treatment is defined by the seizure type. EEG video monitoring is useful for patients where a diagnosis could not be made on the basis of a neurological examination, routine EEG reporting, and ambulatory cassette EEG monitoring.

The majority of the body of evidence published in the peer-reviewed literature consists of retrospective and prospective cohort studies, retrospective studies, and, retrospective reviews. Sample size ranged from 29 to >400 and the mean age ranged from 35 to 52 years. Indications for referral included seizures requiring diagnostic clarification and presurgical evaluation. The duration of seizures across a lifetime was noted in 3 studies, with median/mean values of approximately 15 years with wide ranges. One study included patients that had a new-onset seizure. The studies reported that VEEG altered the diagnosis for some patients. The studies reported changes in antiepileptic drugs (AEDs) as a result of VEEG. The available evidence shows that video electroencephalogram (VEEG) monitoring can provide valuable information to guide the diagnosis and treatment of patients who report seizures when a standard electroencephalogram (EEG) has not provided a clear diagnosis and in patients with refractory epilepsy. Studies have shown that VEEG changed the diagnosis from epileptic seizures to psychogenic non-epileptic seizures (PNES), and the vice versa. In addition, some of the studies reported elimination or reductions in medication after diagnostic changes.

Population Reference No. 3

Policy Statement

[X] Medically Necessary [ ] Investigational

Supplemental Information

N/A

Practice Guidelines and Position Statements

American Board of Internal Medicine’s (ABIM) Foundation Choosing Wisely® Initiative (2017): The American Academy of Neurology (AAN) (2013) recommended that EEG not be performed for headaches. According to the AAN, an EEG offers no advantage over clinical evaluation in diagnosing headaches, nor does it improve outcomes.

American Clinical Neurophysiology Society (ACNS): According to the ACNS, indications for long term EEG monitoring (e.g., ambulatory EEG) included the following:

1. Identification of epileptic paroxysmal electrographic and/or behavioral abnormalities. These included epileptic seizures, overt and subclinical, and documentation of interictal epileptiform discharges.

2. Verification of the epileptic nature of the new “spells” in a patient with previously documented and controlled seizures.

3. Classification of clinical seizure type(s) in a patient with documented but poorly characterized epilepsy

The ACNS further stated that EEG and/or behavioral abnormalities may assist in the differential diagnosis between epileptic disorders and conditions associated with intermittent symptoms due to non-epileptic mechanisms (e.g., syncope, narcolepsy, other sleep disturbances, psychogenic seizures) (ACNS, 2008).

Use Outside of the US

A National Institute for Health and Care Excellence (NICE) guideline on the diagnosis and management of epilepsy stated “long-term video or ambulatory EEG may be used in the assessment of children, young people and adults who present diagnostic difficulties after clinical assessment and standard EEG” (NICE, 2012; 2018).

Medicare National Coverage

CMS National Coverage Determinations (NCDs)

NCD 160.22 Ambulatory EEG Monitoring

CMS Local Coverage Determinations (LCDs)

LCD Medicare Part A Medicare Part B L33399 (EEG – 24 Hour Monitoring) NGS CT, IL, MA, ME, MN, NH, NY, RI, VT, WI CT, IL, MA, ME, MN, NH, NY, RI, VT, WI L33447 (Special Electroencephalography) Palmetto NC , SC , VA, WV L34521 (Special EEG Tests) First Coast FL, PR, VI FL, PR, VI

References

1. American Academy of Neurology. 2017. Billing and Coding FAQ’s. Accessed October 1, 2018. Available at URL address: https://www.aan.com/tools-and-resources/practicing-neurologists-administrators/billingand-coding/coding-faqs/

2. American Board of Internal Medicine’s (ABIM) Foundation Choosing Wisely® Initiative, 2018. American Academy of Neurology (2013). Accessed September 26, 2018. Available at URL address: http://www.choosingwisely.org/clinician-lists/american-academy-neurology-electroencephalography-forheadaches/

3. American Clinical Neurophysiology Society (ACNS). Guideline Twelve: Guidelines for Long-Term Monitoring for Epilepsy. 2008. Accessed: September 26, 2018. Available at URL address: https://www.acns.org/practice/guidelines

4. Aminoff MJ. (author). Chapter 24: Electrophysiology. In: Goetz CG (editor). Textbook of Clinical Neurology. 2nd ed. Chicago: IL: W.B. Saunders Company; 2003.

5. Blume WT. (author). Section 1. Electroencephalography in the diagnosis of nonepileptic and epileptic conditions. In: Kaplan PW, Fisher RS, editors. Imitators of Epilepsy. New York: NY. Demos Medical Publishing, Inc., 2005.

6. Dobrin S. (author). Seizures and Epilepsy in Adolescents and Adults. In: Kellerman, RD, Bope, ET (editors). Conn's Current Therapy 2018. Philadelphia: PA: Elsevier, 2018.

7. Epilepsy Foundation. Diagnosing Epilepsy. 2018. Accessed October 1, 2018. Available at URL address: https://www.epilepsy.com/learn/diagnosing-epilepsy

8. Faulkner HJ, Arima H, Mohamed A. The utility of prolonged outpatient ambulatory EEG. Seizure. 2012 Sep;21(7):491-5.

9. Hussain N, Gayatri N, Blake A, Downey L, Seri S, Whitehouse WP. Ambulatory electroencephalogram in children: A prospective clinical audit of 100 cases. J Pediatr Neurosci. 2013 Sep;8(3):188-91.

10. Kandler R, Ponnusamy A, Wragg C. Video ambulatory EEG: A good alternative to inpatient video telemetry? Seizure. 2017;47:66-70.

11. Keezer MR, Simard-Tremblay E, Veilleux M. The Diagnostic Accuracy of Prolonged Ambulatory Versus Routine EEG. Clin EEG Neurosci. 2016 Apr;47(2):157-61.

12. LaFrance WC, Baker GA, Duncan R, Goldstein LH, Reuber M. Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task Force. Epilepsia 2013;54(11):2005-18. (Reaffirmed 2017 May).

13. Liporace J, Tatum W 4th, Morris GL 3rd, French J. Clinical utility of sleep-deprived versus computer assisted ambulatory 16-channel EEG in epilepsy patients: a multi-center study. Epilepsy Res. 1998 Nov;32(3):357-62.

14. Mesraoua B, Deleu D, Wieser HG. Stevanovic D (Ed.). Long-Term Monitoring: An Overview, Epilepsy - Histological, Electroencephalographic and Psychological Aspects, ISBN: 978-953-51-0082-9, InTech, 2012. Available from: https://www.intechopen.com/books/epilepsy-histological-electroencephalographicand-psychological-aspects/long-term-monitoring-an-overview

15. Moeller J, Haider HA, Hirsch LJ. Electroencephalography (EEG) in the diagnosis of seizures and epilepsy. In: UpToDate, Garcia P (Ed). August 2018. UpToDate, Waltham, MA. (Accessed on September 26, 2018).

16. National Institute for Health and Care Excellence (NICE). Epilepsies: diagnosis and management. Clinical Guidelines [CG137]. January 2012. Updated April 2018. Accessed: September 27, 2018. Available at URL address: https://www.nice.org.uk/guidance/cg137

17. Nuwer M. Assessment of digital EEG, quantitative EEG, and EEG brain mapping: report of the American Academy of Neurology and the American Clinical Neurophysiology Society. Neurology. 1997 Jul;49(1):277-92. Reaffirmed on November 9, 2013. Accessed: October 1, 2018. Available at URL address: https://www.aan.com/Guidelines/home/GuidelineDetail/45

18. Nuwer MR, Coutin-Churchman P. (authors). Chapter 8: Topographic Mapping, Frequency Analysis, and Other Quantitative Techniques in Electroencephalography. In: Aminoff MJ (editor). Aminoff's Electrodiagnosis in Clinical Neurology. 6th ed. Elsevier; 2012

19. Schachter, SC. Evaluation and management of the first seizure in adults. In: UpToDate. Garcia P (Ed). June 2018. UpToDate, Waltham, MA. (Accessed on September 28, 2018).

20. Seneviratne U, Mohamed A, Cook M, D'Souza W. The utility of ambulatory electroencephalography in routine clinical practice: a critical review. Epilepsy Res. 2013 Jul;105(1-2):1-12.

21. Sirven, JI. Evaluation and management of drug-resistant epilepsy. In: UpToDate. Garcia P (Ed). September 2018. UpToDate, Waltham, MA. (Accessed on October 2, 2018)

22. Smith SJ. EEG in the diagnosis, classification, and management of patients with epilepsy. J Neurol Neurosurg Psychiatry. 2005 Jun;76 Suppl 2:ii2-7.

23. St Louis EK, Foldvary-Schaefer, N. Sleep-related epilepsy syndromes. In: UpToDate. Avidan AY, Garcia P (Ed). January 2018. UpToDate, Waltham, MA. (Accessed on October 1, 2018).

24. Stern JM, Engel J. (authors). Chapter 6: Video-EEG Monitoring for Epilepsy. In: Aminoff MJ (editor). Aminoff's Electrodiagnosis in Clinical Neurology. 6th ed. Elsevier; 2012.

25. Tatum WO, Rubboli G, Kaplan PW, Mirsatari SM, Radhakrishnan K, Gloss D, et al. Clinical utility of EEG in diagnosing and monitoring epilepsy in adults. Clin Neurophysiol. 2018 May;129(5):1056-1082.

26. Wirrell E, Kozlik S, Tellez J, Wiebe S, Hamiwka L Ambulatory electroencephalography (EEG) in children: diagnostic yield and tolerability. J Child Neurol. 2008 Jun;23(6):655-62.

Codes

CPT

Number

Description

Codes

95700

Electroencephalogram (EEG) continuous recording, with video when performed, setup, patient education, and takedown when performed, administered in person by EEG technologist, minimum of 8 channels

 

95705

Electroencephalogram (EEG) without video, review of data, technical description by EEG technologist, 2-12 hours; unmonitored

 

95706

Electroencephalogram (EEG) without video, review of data, technical description by EEG technologist, 2-12 hours; unmonitored with intermittent monitoring and maintenance

 

95708

Electroencephalogram (EEG) without video, review of data, technical description by EEG technologist, each increment of 12-26 hours; unmonitored

 

95709

Electroencephalogram (EEG) without video, review of data, technical description by EEG technologist, each increment of 12-26 hours; unmonitored with intermittent monitoring and maintenance

 

95717

Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation and report, 2-12 hours of EEG recording; without video

 

95718

Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation and report, 2-12 hours of EEG recording; with video (VEEG)

 

95719

Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; without video

 

95720

Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG)

 

95721

Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study; greater than 36 hours, up to 60 hours of EEG recording, without video

 

95722

Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study; greater than 36 hours, up to 60 hours of EEG recording, with video (VEEG)

 

95723

Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study; greater than 60 hours, up to 84 hours of EEG recording, without video 

 

 95724

Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study; greater than 60 hours, up to 84 hours of EEG recording, with video (VEEG) 

 

95725

Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study; greater than 84 hours of EEG recording, without video 

 

95726

Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study; greater than 84 hours of EEG recording, with video (VEEG) 

 

95812

Electroencephalogram (EEG) extended monitoring; 41-60 minutes

 

95813

Electroencephalogram (EEG) extended monitoring; 61-119 minutes

 

95819

Electroencephalogram (EEG), including recording awake and asleep, with hyperventilation and/or photic stimulation

 

95822

Electroencephalogram (EEG); recording in coma or sleep only

 

95824

Electroencephalogram (EEG); cerebral death evaluation only

 

95955

Electroencephalogram (EEG) during nonintracranial surgery (eg, carotid surgery)

HCPCS

A4556

Electrodes (e.g., apnea monitor), per pair

ICD-10 CM

E03.5

Myxedema coma

 

F51.8

Other sleep disorders not due to a substance or known physiological condition

 

G40.001

Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, with status epilepticus

 

G40.009

Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus

 

G40.011

Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, with status epilepticus

 

G40.019

Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus

 

G40.101

Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, with status epilepticus

 

G40.109

Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus

 

G40.111

Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, with status epilepticus

 

G40.201

Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, with status epilepticus

 

G40.209

Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus

 

G40.211

Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, with status epilepticus

 

G40.219

Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus

 

G40.301

Generalized idiopathic epilepsy and epileptic syndromes, not intractable, with status epilepticus

 

G40.309

Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus

 

G40.311

Generalized idiopathic epilepsy and epileptic syndromes, intractable, with status epilepticus

 

G40.319

Generalized idiopathic epilepsy and epileptic syndromes, intractable, without status epilepticus

 

G40.401

Other generalized epilepsy and epileptic syndromes, not intractable, with status epilepticus

 

G40.409

Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus

 

G40.411

Other generalized epilepsy and epileptic syndromes, intractable, with status epilepticus

 

G40.419

Other generalized epilepsy and epileptic syndromes, intractable, without status epilepticus

 

G40.501

Epileptic seizures related to external causes, not intractable, with status epilepticus

 

G40.509

Epileptic seizures related to external causes, not intractable, without status epilepticus

 

G40.801

Other epilepsy, not intractable, with status epilepticus

 

G40.802

Other epilepsy, not intractable, without status epilepticus

 

G40.803

Other epilepsy, intractable, with status epilepticus

 

G40.804

Other epilepsy, intractable, without status epilepticus

 

G40.811

Lennox-Gastaut syndrome, not intractable, with status epilepticus

 

G40.812

Lennox-Gastaut syndrome, not intractable, without status epilepticus

 

G40.813

Lennox-Gastaut syndrome, intractable, with status epilepticus

 

G40.814

Lennox-Gastaut syndrome, intractable, without status epilepticus

 

G40.821

Epileptic spasms, not intractable, with status epilepticus

 

G40.822

Epileptic spasms, not intractable, without status epilepticus

 

G40.823

Epileptic spasms, intractable, with status epilepticus

 

G40.824

Epileptic spasms, intractable, without status epilepticus

 

G40.89

Other seizures

 

G40.901

Epilepsy, unspecified, not intractable, with status epilepticus

 

G40.909

Epilepsy, unspecified, not intractable, without status epilepticus

 

G40.911

Epilepsy, unspecified, intractable, with status epilepticus

 

G40.919

Epilepsy, unspecified, intractable, without status epilepticus

 

G40.A01

Absence epileptic syndrome, not intractable, with status epilepticus

 

G40.A09

Absence epileptic syndrome, not intractable, without status epilepticus

 

G40.A11

Absence epileptic syndrome, intractable, with status epilepticus

 

G40.A19

Absence epileptic syndrome, intractable, without status epilepticus

 

G40.B01

Juvenile myoclonic epilepsy, not intractable, with status epilepticus

 

G40.B09

Juvenile myoclonic epilepsy, not intractable, without status epilepticus

 

G40.B11

Juvenile myoclonic epilepsy, intractable, with status epilepticus

 

G40.B19

Juvenile myoclonic epilepsy, intractable, without status epilepticus

 

G43.109

Migraine with aura, not intractable, without status migrainosus

 

G43.119

Migraine with aura, intractable, without status migrainosus

 

G43.809

Other migraine, not intractable, without status migrainosus

 

G43.909

Migraine, unspecified, not intractable, without status migrainosus

 

G47.00

Insomnia, unspecified

 

G47.10

Hypersomnia, unspecified

 

G47.12

Idiopathic hypersomnia without long sleep time

 

G47.19

Other hypersomnia

 

G47.20

Circadian rhythm sleep disorder, unspecified type

 

G47.30

Sleep apnea, unspecified

 

G47.411

Narcolepsy with cataplexy

 

G47.419

Narcolepsy without cataplexy

 

G47.421

Narcolepsy in conditions classified elsewhere with cataplexy

 

G47.429

Narcolepsy in conditions classified elsewhere without cataplexy

 

G47.8

Other sleep disorders

 

G47.9

Sleep disorder, unspecified

 

 G93.31

Postviral fatigue syndrome

 

G93.32

Myalgic encephalomyelitis/chronic fatigue syndrome

 

G93.39

Other post infection and related fatigue syndromes

 

R10.84

Generalized abdominal pain

 

R40.0

Somnolence

 

R40.1

Stupor

 

R40.20

Unspecified coma

 

R40.2110

Coma scale, eyes open, never, unspecified time

 

R40.2111

Coma scale, eyes open, never, in the field [EMT or ambulance]

 

R40.2112

Coma scale, eyes open, never, at arrival to emergency department

 

R40.2113

Coma scale, eyes open, never, at hospital admission

 

R40.2114

Coma scale, eyes open, never, 24 hours or more after hospital admission

 

R40.2120

Coma scale, eyes open, to pain, unspecified time

 

R40.2121

Coma scale, eyes open, to pain, in the field [EMT or ambulance]

 

R40.2122

Coma scale, eyes open, to pain, at arrival to emergency department

 

R40.2123

Coma scale, eyes open, to pain, at hospital admission

 

R40.2124

Coma scale, eyes open, to pain, 24 hours or more after hospital admission

 

R40.2130

Coma scale, eyes open, to sound, unspecified time

 

R40.2131

Coma scale, eyes open, to sound, in the field [EMT or ambulance]

 

R40.2132

Coma scale, eyes open, to sound, at arrival to emergency department

 

R40.2133

Coma scale, eyes open, to sound, at hospital admission

 

R40.2134

Coma scale, eyes open, to sound, 24 hours or more after hospital admission

 

R40.2140

Coma scale, eyes open, spontaneous, unspecified time

 

R40.2141

Coma scale, eyes open, spontaneous, in the field [EMT or ambulance]

 

R40.2142

Coma scale, eyes open, spontaneous, at arrival to emergency department

 

R40.2144

Coma scale, eyes open, spontaneous, 24 hours or more after hospital admission

 

R40.2210

Coma scale, best verbal response, none, unspecified time

 

R40.2211

Coma scale, best verbal response, none, in the field [EMT or ambulance]

 

R40.2212

Coma scale, best verbal response, none, at arrival to emergency department

 

R40.2213

Coma scale, best verbal response, none, at hospital admission

 

R40.2214

Coma scale, best verbal response, none, 24 hours or more after hospital admission

 

R40.2220

Coma scale, best verbal response, incomprehensible words, unspecified time

 

R40.2221

Coma scale, best verbal response, incomprehensible words, in the field [EMT or ambulance]

 

R40.2222

Coma scale, best verbal response, incomprehensible words, at arrival to emergency department

 

R40.2223

Coma scale, best verbal response, incomprehensible words, at hospital admission

 

R40.2224

Coma scale, best verbal response, incomprehensible words, 24 hours or more after hospital admission

 

R40.2230

Coma scale, best verbal response, inappropriate words, unspecified time

 

R40.2231

Coma scale, best verbal response, inappropriate words, in the field [EMT or ambulance]

 

R40.2232

Coma scale, best verbal response, inappropriate words, at arrival to emergency department

 

R40.2233

Coma scale, best verbal response, inappropriate words, at hospital admission

 

R40.2234

Coma scale, best verbal response, inappropriate words, 24 hours or more after hospital admission

 

R40.2240

Coma scale, best verbal response, confused conversation, unspecified time

 

R40.2241

Coma scale, best verbal response, confused conversation, in the field [EMT or ambulance]

 

R40.2242

Coma scale, best verbal response, confused conversation, at arrival to emergency department

 

R40.2243

Coma scale, best verbal response, confused conversation, at hospital admission

 

R40.2244

Coma scale, best verbal response, confused conversation, 24 hours or more after hospital admission

 

R40.2250

Coma scale, best verbal response, oriented, unspecified time

 

R40.2251

Coma scale, best verbal response, oriented, in the field [EMT or ambulance]

 

R40.2252

Coma scale, best verbal response, oriented, at arrival to emergency department

 

R40.2253

Coma scale, best verbal response, oriented, at hospital admission

 

R40.2254

Coma scale, best verbal response, oriented, 24 hours or more after hospital admission

 

R40.2310

Coma scale, best motor response, none, unspecified time

 

R40.2311

Coma scale, best motor response, none, in the field [EMT or ambulance]

 

R40.2312

Coma scale, best motor response, none, at arrival to emergency department

 

R40.2313

Coma scale, best motor response, none, at hospital admission

 

R40.2314

Coma scale, best motor response, none, 24 hours or more after hospital admission

 

R40.2320

Coma scale, best motor response, extension, unspecified time

 

R40.2321

Coma scale, best motor response, extension, in the field [EMT or ambulance]

 

R40.2322

Coma scale, best motor response, extension, at arrival to emergency department

 

R40.2323

Coma scale, best motor response, extension, at hospital admission

 

R40.2324

Coma scale, best motor response, extension, 24 hours or more after hospital admission

 

R40.2330

Coma scale, best motor response, abnormal, unspecified time

 

R40.2331

Coma scale, best motor response, abnormal, in the field [EMT or ambulance]

 

R40.2332

Coma scale, best motor response, abnormal, at arrival to emergency department

 

R40.2333

Coma scale, best motor response, abnormal, at hospital admission

 

R40.2334

Coma scale, best motor response, abnormal, 24 hours or more after hospital admission

 

R40.2340

Coma scale, best motor response, flexion withdrawal, unspecified time

 

R40.2341

Coma scale, best motor response, flexion withdrawal, in the field [EMT or ambulance]

 

R40.2342

Coma scale, best motor response, flexion withdrawal, at arrival to emergency department

 

R40.2343

Coma scale, best motor response, flexion withdrawal, at hospital admission

 

R40.2344

Coma scale, best motor response, flexion withdrawal, 24 hours or more after hospital admission

 

R40.2350

Coma scale, best motor response, localizes pain, unspecified time

 

R40.2351

Coma scale, best motor response, localizes pain, in the field [EMT or ambulance]

 

R40.2352

Coma scale, best motor response, localizes pain, at arrival to emergency department

 

R40.2353

Coma scale, best motor response, localizes pain, at hospital admission

 

R40.2354

Coma scale, best motor response, localizes pain, 24 hours or more after hospital admission

 

R40.2360

Coma scale, best motor response, obeys commands, unspecified time

 

R40.2361

Coma scale, best motor response, obeys commands, in the field [EMT or ambulance]

 

R40.2362

Coma scale, best motor response, obeys commands, at arrival to emergency department

 

R40.3

Persistent vegetative state

 

R40.4

Transient alteration of awareness

 

R41.0

Disorientation, unspecified

 

R41.1

Anterograde amnesia

 

R41.2

Retrograde amnesia

 

R41.3

Other amnesia

 

R41.82

Altered mental status, unspecified

 

R41.9

Unspecified symptoms and signs involving cognitive functions and awareness

 

R42

Dizziness and giddiness

 

R44.0

Auditory hallucinations

 

R44.2

Other hallucinations

 

R44.3

Hallucinations, unspecified

 

R45.83

Excessive crying of child, adolescent or adult

 

R45.84

Anhedonia

 

R50.2

Drug induced fever

 

R50.81

Fever presenting with conditions classified elsewhere

 

R50.82

Postprocedural fever

 

R50.83

Postvaccination fever

 

R50.84

Febrile nonhemolytic transfusion reaction

 

R50.9

Fever, unspecified

 

R52

Pain, unspecified

 

R53.0

Neoplastic (malignant) related fatigue

 

R53.2

Functional quadriplegia

 

R53.81

Other malaise

 

R53.82

Chronic fatigue, unspecified

 

R53.83

Other fatigue

 

R55

Syncope and collapse

 

R56.00

Simple febrile convulsions

 

R56.01

Complex febrile convulsions

 

R56.1

Post traumatic seizures

 

R56.9

Unspecified convulsions

 

R61

Generalized hyperhidrosis

 

R68.0

Hypothermia, not associated with low environmental temperature

 

R68.11

Excessive crying of infant (baby)

 

R68.12

Fussy infant (baby)

 

R68.81

Early satiety

 

R68.83

Chills (without fever)

 

R68.89

Other general symptoms and signs

 

S01.90xA

Unspecified open wound of unspecified part of head, initial encounter

 

S01.90xD

Unspecified open wound of unspecified part of head, subsequent encounter

 

S01.90xS

Unspecified open wound of unspecified part of head, sequela

 

S06.340A

Traumatic hemorrhage of right cerebrum without loss of consciousness, initial encounter

 

S06.340D

Traumatic hemorrhage of right cerebrum without loss of consciousness, subsequent encounter

 

S06.340S

Traumatic hemorrhage of right cerebrum without loss of consciousness, sequela

 

S06.343A

Traumatic hemorrhage of right cerebrum with loss of consciousness of 1 hours to 5 hours 59 minutes, initial encounter

 

S06.343D

Traumatic hemorrhage of right cerebrum with loss of consciousness of 1 hours to 5 hours 59 minutes, subsequent encounter

 

S06.343S

Traumatic hemorrhage of right cerebrum with loss of consciousness of 1 hours to 5 hours 59 minutes, sequela

 

S06.344A

Traumatic hemorrhage of right cerebrum with loss of consciousness of 6 hours to 24 hours, initial encounter

 

S06.344D

Traumatic hemorrhage of right cerebrum with loss of consciousness of 6 hours to 24 hours, subsequent encounter

 

S06.344S

Traumatic hemorrhage of right cerebrum with loss of consciousness of 6 hours to 24 hours, sequela

 

S06.345A

Traumatic hemorrhage of right cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter

 

S06.345D

Traumatic hemorrhage of right cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter

 

S06.345S

Traumatic hemorrhage of right cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela

 

S06.346A

Traumatic hemorrhage of right cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter

 

S06.346D

Traumatic hemorrhage of right cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter

 

S06.346S

Traumatic hemorrhage of right cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela

 

S06.350A

Traumatic hemorrhage of left cerebrum without loss of consciousness, initial encounter

 

S06.350D

Traumatic hemorrhage of left cerebrum without loss of consciousness, subsequent encounter

 

S06.350S

Traumatic hemorrhage of left cerebrum without loss of consciousness, sequela

 

S06.353A

Traumatic hemorrhage of left cerebrum with loss of consciousness of 1 hours to 5 hours 59 minutes, initial encounter

 

S06.353D

Traumatic hemorrhage of left cerebrum with loss of consciousness of 1 hours to 5 hours 59 minutes, subsequent encounter

 

S06.353S

Traumatic hemorrhage of left cerebrum with loss of consciousness of 1 hours to 5 hours 59 minutes, sequela

 

S06.354A

Traumatic hemorrhage of left cerebrum with loss of consciousness of 6 hours to 24 hours, initial encounter

 

S06.354D

Traumatic hemorrhage of left cerebrum with loss of consciousness of 6 hours to 24 hours, subsequent encounter

 

S06.354S

Traumatic hemorrhage of left cerebrum with loss of consciousness of 6 hours to 24 hours, sequela

 

S06.355A

Traumatic hemorrhage of left cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter

 

S06.355D

Traumatic hemorrhage of left cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter

 

S06.355S

Traumatic hemorrhage of left cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela

 

S06.356A

Traumatic hemorrhage of left cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter

 

S06.356D

Traumatic hemorrhage of left cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter

 

S06.356S

Traumatic hemorrhage of left cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela

 

S06.360A

Traumatic hemorrhage of cerebrum, unspecified, without loss of consciousness, initial encounter

 

S06.360D

Traumatic hemorrhage of cerebrum, unspecified, without loss of consciousness, subsequent encounter

 

S06.360S

Traumatic hemorrhage of cerebrum, unspecified, without loss of consciousness, sequela

 

S06.363A

Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 1 hours to 5 hours 59 minutes, initial encounter

 

S06.363D

Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 1 hours to 5 hours 59 minutes, subsequent encounter

 

S06.363S

Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 1 hours to 5 hours 59 minutes, sequela

 

S06.364A

Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 6 hours to 24 hours, initial encounter

 

S06.364D

Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 6 hours to 24 hours, subsequent encounter

 

S06.364S

Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 6 hours to 24 hours, sequela

 

S06.365A

Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter

 

S06.365D

Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter

 

S06.365S

Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela

 

S06.4X3A

Epidural hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter

 

S06.4X3D

Epidural hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter

 

S06.4X3S

Epidural hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela

 

S06.4X5A

Epidural hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter

 

S06.4X5D

Epidural hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter

 

S06.4X5S

Epidural hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela

 

S06.5X0A

Traumatic subdural hemorrhage without loss of consciousness, initial encounter

 

S06.5X0D

Traumatic subdural hemorrhage without loss of consciousness, subsequent encounter

 

S06.5X0S

Traumatic subdural hemorrhage without loss of consciousness, sequela

 

S06.5X1A

Traumatic subdural hemorrhage with loss of consciousness of 30 minutes or less, initial encounter

 

S06.5X1D

Traumatic subdural hemorrhage with loss of consciousness of 30 minutes or less, subsequent encounter

 

S06.5X1S

Traumatic subdural hemorrhage with loss of consciousness of 30 minutes or less, sequela

 

S06.5X2A

Traumatic subdural hemorrhage with loss of consciousness of 31 minutes to 59 minutes, initial encounter

 

S06.5X2D

Traumatic subdural hemorrhage with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter

 

S06.5X2S

Traumatic subdural hemorrhage with loss of consciousness of 31 minutes to 59 minutes, sequela

 

S06.5X3A

Traumatic subdural hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter

 

S06.5X3D

Traumatic subdural hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter

 

S06.5X3S

Traumatic subdural hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela

 

S06.5X4A

Traumatic subdural hemorrhage with loss of consciousness of 6 hours to 24 hours, initial encounter

 

S06.5X4D

Traumatic subdural hemorrhage with loss of consciousness of 6 hours to 24 hours, subsequent encounter

 

S06.5X4S

Traumatic subdural hemorrhage with loss of consciousness of 6 hours to 24 hours, sequela

 

S06.5X5A

Traumatic subdural hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter

 

S06.5X5D

Traumatic subdural hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter

 

S06.5X5S

Traumatic subdural hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela

 

S06.5X6A

Traumatic subdural hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter

 

S06.5X6D

Traumatic subdural hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter

 

S06.5X6S

Traumatic subdural hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela

 

S06.5X7A

Traumatic subdural hemorrhage with loss of consciousness of any duration with death due to brain injury before regaining consciousness, initial encounter

 

S06.5X7D

Traumatic subdural hemorrhage with loss of consciousness of any duration with death due to brain injury before regaining consciousness, subsequent encounter

 

S06.5X7S

Traumatic subdural hemorrhage with loss of consciousness of any duration with death due to brain injury before regaining consciousness, sequela

 

S06.5X8A

Traumatic subdural hemorrhage with loss of consciousness of any duration with death due to other cause before regaining consciousness, initial encounter

 

S06.5X8D

Traumatic subdural hemorrhage with loss of consciousness of any duration with death due to other cause before regaining consciousness, subsequent encounter

 

S06.5X8S

Traumatic subdural hemorrhage with loss of consciousness of any duration with death due to other cause before regaining consciousness, sequela

 

S06.5X9A

Traumatic subdural hemorrhage with loss of consciousness of unspecified duration, initial encounter

 

S06.5X9D

Traumatic subdural hemorrhage with loss of consciousness of unspecified duration, subsequent encounter

 

S06.5X9S

Traumatic subdural hemorrhage with loss of consciousness of unspecified duration, sequela

 

S06.6X0A

Traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter

 

S06.6X0D

Traumatic subarachnoid hemorrhage without loss of consciousness, subsequent encounter

 

S06.6X0S

Traumatic subarachnoid hemorrhage without loss of consciousness, sequela

 

S06.6X3A

Traumatic subarachnoid hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter

 

S06.6X3D

Traumatic subarachnoid hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter

 

S06.6X3S

Traumatic subarachnoid hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela

 

S06.6X4A

Traumatic subarachnoid hemorrhage with loss of consciousness of 6 hours to 24 hours, initial encounter

 

S06.6X4D

Traumatic subarachnoid hemorrhage with loss of consciousness of 6 hours to 24 hours, subsequent encounter

 

S06.6X4S

Traumatic subarachnoid hemorrhage with loss of consciousness of 6 hours to 24 hours, sequela

 

S06.6X5A

Traumatic subarachnoid hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter

 

S06.6X5D

Traumatic subarachnoid hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter

 

S06.6X5S

Traumatic subarachnoid hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela

 

S06.6X6A

Traumatic subarachnoid hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter

 

S06.6X6D

Traumatic subarachnoid hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter

 

S06.6X6S

Traumatic subarachnoid hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela

Policy History

Date

Action

Description

07/11/23

Annual Review

Minor editorial refinements to policy statement; intent unchanged.

07/11/22

Annual Review

Change ICD-10 CM (Add ICD-10 CM G93.31, G93.32, G93.39, effective date 10/01/2022), (Delete ICD-10 CM G93.3, termination date 09/30/2022)

12/20/19

Replace policy

Code deleted 95827, 95950, 95951, 95953, 95956, termination date 12/31/2019.  Included CPT code, effective date 01/01/2020.

09/02/19

Annual review

Review of literature

09/16/16

Policy Archived

 

10/28/15

 

 

09/30/13

 

 

09/09/13

 

 

10/25/11

 

 

04/13/09

 

iCES

04/18/07

 

 

02/15/05

 

 

12/18/03

 

 

06/2000

 

 

09/13/99